Donor-virus-specific CMV/AdV cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-virus-specific CMV/AdV cytotoxic T lymphocytes, covering 2026-04-15 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT [EARLY_Phase 1]